Wealth Enhancement Advisory Services, LLC Cytokinetics Inc Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 8,476 shares of CYTK stock, worth $306,492. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,476
Previous 6,488
30.64%
Holding current value
$306,492
Previous $260,000
7.69%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CYTK
# of Institutions
394Shares Held
126MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$531 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$428 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$360 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$289 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$220 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.4B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...